Issue 68, 2015

Multifunctional nanoparticles: recent progress in cancer therapeutics

Abstract

Although much progress has been made in treating cancers, cancer death rates in and around the United States are still high. Current treatments are either ineffective against some cancers or detrimental to patients, which decreases their quality of life. The use of nanotechnology in cancer therapy can potentially increase patient survival, reduce side effects, and reduce mortality rates because nanoparticles (NPs) have the potential to target only tumors and bypass healthy cells. NPs possess many features, including size, shape, charge, and composition, which allow them to carry chemotherapeutics to cancer cells. NPs can also be used in radiotherapy as radiosensitizers and in imaging as contrast agents. Many studies have performed in vitro and/or in vivo experiments on these particles in human and animal cell lines. This review discusses recent studies on different NPs and their potential use in cancer therapy.

Graphical abstract: Multifunctional nanoparticles: recent progress in cancer therapeutics

Article information

Article type
Feature Article
Submitted
05 Jun 2015
Accepted
21 Jul 2015
First published
21 Jul 2015
This article is Open Access
Creative Commons BY license

Chem. Commun., 2015,51, 13248-13259

Multifunctional nanoparticles: recent progress in cancer therapeutics

G. Seeta Rama Raju, L. Benton, E. Pavitra and J. S. Yu, Chem. Commun., 2015, 51, 13248 DOI: 10.1039/C5CC04643B

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements